Search research articles
Contact Us
Tim Walsteijn
1
PUBLICATIONS
0
CO-AUTHORS
Predictive and prognostic markers
Get your video featured.
Publish with JoVE
Get your video featured.
Publish with JoVE
Publications
(1)
Sort by Publication Date:
Latest
Oncology and therapy
|
May 17, 2025
A Cost-Effectiveness Analysis for Avelumab as a First-Line Maintenance Treatment of Advanced Urothelial Carcinoma in the Netherlands.
David Smalbrugge, Tim Walsteijn, Jeantine de Feijter
+5
Page
of 1
Frequent Collaborators
Frequent Collaborators
See all collaborators